Skip to Content

nav = $navtool.getNav(1)

CCTS announces 2024 TL1 trainee cohort

January 25, 2024
Tracey Barnett/ MD Anderson UTHealth Houston Graduate School

CCTS announces 2024 TL1 trainee cohort

The Predoctoral & Postdoctoral Training in Clinical & Translational Sciences at UTHealth Houston and MD Anderson Cancer Center is proud to announce the 2024 recipients, which includes 13 Graduate School students:


Meagan Conner – Cancer Biology Program; Advisor: Raghu Kalluri, MD, PhD

Maryam Elizondo – Therapeutics and Pharmacology Program; Advisor: Kai Sun, MD, PhD

Stephen Farmer – Immunology Program; Advisor: Sheng Zhang, PhD

Kaira Church – Cancer Biology Program; Advisor: Raghu Kalluri, MD, PhD

Jacob Mattia – Molecular and Translational Biology Program; Advisor: Wenbo Li, PhD

Nicolas Moreno – Molecular and Translational Biology Program; Advisor: Changqing (Cynthia) Ju, PhD

Samuel Mulder – Medical Physics Program; Advisor: Clifton Fuller, MD, PhD

Grace Isakson-Murley – Quantitative Sciences Program; Advisor: Mark Pagel, PhD

Morgan Riba – Immunology Program; Advisor: Stephanie Watowich, PhD

Lea Stitzlein – Therapeutics and Pharmacology Program; Advisor: Joya Chandra, PhD

Gemalene Sunga – Immunology Program; Advisor: Simon Young, DDS, MD, PhD

Trey Waldrop – Cancer Biology Program; Advisor: Emil Schueler, PhD

Brandy Walker – Genetics and Epigenetics Program; Advisor: Rachel Miller, Ph.D.

 

Postdoctoral trainees include:

Antonio Pagan – Psychiatry & Behavioral Sciences (McGovern Medical School at UTHealth Houston); Advisor: Katherine Loveland, PhD

Lacin Yapindi - Thoracic/Head and Neck Medical Oncology (MD Anderson); Advisor: Faye Johnson, MD, PhD

 

These trainees will have the opportunity to create and adapt laboratory discoveries for the treatment of human disease. The University of Texas Center for Clinical and Translational Sciences (CCTS) serves as the central organizing entity for all the Houston Clinical and Translational Science Awards, which includes TL1. The TL1 program is open to PhD (including MD/PhD) predoctoral students from across the six UTHealth Houston Schools and postdoctoral trainees at UTHealth Houston and MD Anderson Cancer Center who meet the eligibility criteria.

site var = gsbs